Publication | Closed Access

A phase II randomized clinical trial of the effect of metformin versus placebo on progression-free survival in women with metastatic breast cancer receiving standard chemotherapy

Metastatic Breast CancerOncologyBreast OncologyMedicineMetformin Versus PlaceboCancer ManagementClinical TrialsBreast CancerPharmacotherapyCancer TreatmentPharmacologyPhase Ii